CYP3A4功能变异对齐普拉西代谢的影响
Qi Zhou1,2, Yameng Wu1, Zhize Ye3
1Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
奎尔塞丁通过影响CYP3A4酶活性来抑制齐普拉西的代谢. CYP3A4的遗传变异也影响着齐普拉西的处理方式,影响药物的有效性和安全性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物新陈代谢 药物新陈代谢
- 酶动力学 酶动力学
背景情况:
- 齐普拉西的新陈代谢主要由细胞染色体P450 3A4 (CYP3A4) 酶进行介导.
- CYP3A4具有显著的遗传变异性,并且通过抑制或诱导容易发生药物相互作用.
研究的目的:
- 为了研究CYP3A4在齐普拉西代谢中的功能变异性.
- 探索药物相互作用,特别是素和遗传多形态对齐普拉西药理学的影响.
主要方法:
- 在实验室中使用大鼠肝显微体 (RLM),人类肝显微体 (HLM) 和CYP3A4细菌体的研究来评估代谢抑制和动力学.
- 在Sprague-Dawley大鼠体内验证.
- 分析各种CYP3A4遗传变体和分子对接,以确定关键相互作用残留物.
主要成果:
- 奎尔塞丁在体外显著抑制了齐普拉西代谢,并在体内增加了齐普拉西暴露.
- CYP3A4变体表现出不同的代谢效率,其中一些表现出增加的活性,另一些表现出减少的活性.
- 奎尔塞丁的抑制作用在不同的CYP3A4等位基上有所不同,并且确定了参与抑制的关键氨基酸残留物.
结论:
- 奎尔塞丁介导的CYP3A4抑制在改变齐普拉西代谢中起着至关重要的作用.
- 在CYP3A4中的遗传多态性显著影响齐普拉西的代谢途径和药物反应.
更多相关视频
08:59An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
The drug's acidity or basicity is essential in...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Nonlinear Pharmacokinetics: Causes of Nonlinearity
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear Pharmacokinetics: Role of Transporters
Polymorphisms occurring in drug transporters can alter...
